Platelet membrane fluidity and peroxynitrite levels in migraine patients during headache-free periods

Cephalalgia

Volumn 25, Issue 5, 2005, Pages 353-358

  Taffi, R ^a   Vignini, A ^a   Lanciotti, C ^a   Luconi, R ^a   Nanetti, L ^a   Mazzanti, L ^a   Provinciali, L ^a   Silvestrini, M ^a   Bartolini, M ^a  

^a UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

Author keywords

Migraine; Peroxynitrite; Platelet membrane

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); ARGININE; DICHLOROFLUORESCEIN; ENDOTHELIAL NITRIC OXIDE SYNTHASE; INDUCIBLE NITRIC OXIDE SYNTHASE; NITRIC OXIDE; PEROXYNITRITE;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; HEADACHE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOBLOTTING; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; MEMBRANE FLUIDITY; MIGRAINE; OXIDATIVE STRESS; PATHOPHYSIOLOGY; STATISTICAL SIGNIFICANCE; STEADY STATE; THROMBOCYTE MEMBRANE; UNCERTAINTY; WESTERN BLOTTING;

ADULT; BLOOD PLATELETS; FEMALE; HUMANS; MALE; MEMBRANE FLUIDITY; MIGRAINE DISORDERS; PEROXYNITROUS ACID;

EID: 17644410792     PISSN: 03331024     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1468-2982.2004.00863.x     Document Type: Article

References (31)

1. D'Andrea G, Cananzi AR, Perini F, Alecci M, Zamberlan F, Hasselmark L, et al. Decreased collagen-induced platelet aggregation and increased platelet arginine levels in migraine: a possible link with the NO pathway. Cephalalgia 1994; 14:352-6.
2. Shimomura T, Murakami F, Kotani K, Ikawa S, Kono S. Platelet nitric oxide metabolites in migraine. Cephalalgia 1999; 19:218-22.
3. Thomsen LL, Olesen J. Nitric oxide theory of migraine. Clin Neurosci 1998; 5:28-33.
4. Gallai V, Floridi A, Mazzotta G, Codini M, Tognoloni M, Vulcano MR, et al. 1-arginine/nitric oxide pathway activation in platelets of migraine patients with and without aura. Acta Neurol Scand 1996; 94:151-60.
5. Shukla R, Barthwal MK, Srivastava N, Nag D, Seth PK, Srimal RC, et al. Blood nitrite levels in patients with migraine during headache-free period. Headache 2001; 41:475-81.
6. Knolwles RG, Moncada S. Nitric oxide synthases in mammals. Biochem J 1994; 298:249-58.
7. Ayajiki K, Okamura T, Toda N. Involvement of nitric oxide in endothelium-dependent, phasic relaxation caused by histamine in monkey cerebral arteries. Jpn J Pharmacol 1992; 60:357-62.
8. Stuehr DJ, Cho HJ, Kwon NS, Weise MF, Nathan CF. Purification and characterization of the cytokine-induced macrophage nitric oxide synthase. an FAD and FMN containing flavoprotein. Proc Natl Acad Sci USA 1991; 88:7773-7.
9. Busse R, Mulsch A. Induction of nitric oxide synthase by cytokines in vascular smooth muscle cells. FEBS Lett 1990; 275:87-90.
10. Headache Classification Subcommittee of the international Headache Society. The International Classification of Headache Disorders, 2nd edn. Cephalalgia 2004; 24 Suppl 1:1-160.
11. Rao GH. Measurement of ionised calcium in normal human blood platelets. Annal Biochem 1988; 169:400-4.
12. Tannous M, Rabini RA, Vignini A, Moretti N, Fumelli P, Zielinski B, et al. Evidence for iNOS-dependent peroxynitrite production in diabetic platelets. Diabetologia 1999; 42:539-54.
13. 2+-transport system. Biochem J 1989; 263:547-52.
14. Mazzanti L, Rabini RA, Faloia E, Fumelli P, Bertoli E, De Pirro R. Altered cellular calcium and sodium transport in diabetes mellitus. Diabetes 1990; 39:850-4.
15. Fiske CH, Subbarow Y. The colorimetric determination of phosphorus. J Biol Chem 1925; 66:375-400.
16. Kitao T, Hattori K. Inhibition of erythrocyte ATPase activity by aclacinomycin and reverse effect of ascorbate on ATPase activity. Experientia 1983; 39:1362-4.
17. Bradford M. A rapid and sensitive Method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72:248-54.
18. Sheridan NP, Block ER. Plasma membrane fluidity measurements in intact endothelial cells, effect of hyperoxia on fluorescence anisotropies of 1-[4-(trimethylamino) phenyl]-6-phenylhexa-1,3,5-Triene. J Cell Physiol 1988; 134:117-23.
19. Couch JR, Hassanein RS. Platelet aggregability in migraine. Neurology 1977; 27:843-8.
20. Oxman TE, Hitzemann RJ, Smith R. Platelet membrane lipid composition and the frequency of migraine. Headache 1982; 22:403-10.
21. Olesen J, Jansen-Olesen I. Nitric oxide mechanism in migraine. Pathol Biol 2000; 48:648-57.
22. Olesen J. Discussion summary: involvement of nitric oxide-cyclic GMP pathway products in primary headache. In: Olesen J, Edvinsson L, editors. Headache Pathogenesis. Monoamnines, Neuropeptides, Purines, and Nitric Oxide, Vol. 7. Philadelphia: Lippincott-Raven Press, 1997:303-6.
23. Ischiropoulos H, Zhu L, Chen J, Tsai M, Martin JC, Smith CD, et al. Peroxynitrite-mediated tyrosine nitration catalyzed by superoxide dismutase. Arch Biochem Biophys 1992; 298:431-7.
24. + ATPase activity. Nitric Oxide 2000; 4:333-42.
25. Szabo C. Multiple pathway of peroxynitritecytotoxicity. Toxicol Lett 2003; 140-141:105-12.
26. Virag L, Szabo E, Gergely P, Szabo C. Peroxynitrite-induced cytotoxicity: mechanism and opportunities for intervention. Toxicol Lett 2003; 140-141:113-24.
27. Mazzanti L, Rabini RA, Fumelli P, Martarelli D, Staffolani R, Salvolini E, et al. Altered platelet membrane dynamic properties in type 1 diabetes. Diabetes 1997; 46:2069-74).
28. Skou JC, Esmann M, The Na K-AT, Pase. J Bioenerg Biomembr 1992; 24:249-61.
29. Stubbs CD, Smith AD. The modification of mammalian membrane polyunsaturated fatty acid composition in relation to membrane fluidity and function. Biochim Biophys Acta 1984; 779:89-137).
30. Gao F, Yao CL, Gao E, Mo QZ, Van WL, Mclaughlin R, et al. Enhancement of glutathione cardioprotection by ascorbic acid in myocardial reperfusion injury. J Pharmacol Exp Ther 2002; 301:543-50.
31. Gilad E, Cuzzocrea S, Zingarelli B, Salzman AL, Szabo C. Melatonin is a scavenger of peroxynitrite. Life Sci 1997; 60:169-7.